Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect
Phase I Study of Human Umbilical Cord Mesenchymal Stem Cell Implantation in the Treatment of Articular Cartilage Defect of Knee
Sponsor: Fifth Affiliated Hospital of Guangzhou Medical University
A PHASE1 clinical study on Cartilage Diseases and Osteoarthritis, this trial is completed. The trial is conducted by Fifth Affiliated Hospital of Guangzhou Medical University and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Feb 2023 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
Jun 2017 — Jun 2018 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fifth Affiliated Hospital of Guangzhou Medical University
- Shenzhen Hornetcorn Bio-technology Company, LTD
For direct contact, visit the study record on ClinicalTrials.gov .